-
Applied Molecular Transport Inc. NASDAQ:AMTI Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT's proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelium (IE) barrier. Active transport is an efficient mechanism that uses the cell's own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease. AMT's headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA.
Location: | Website: appliedmt.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.62%
Insider Ownership
21.36%
Institutional Own.
37.28%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AMT-101 (IL-10 oral agonist) Details Ulcerative colitis, Rheumatoid arthritis, Pouchitis | Phase 3 Initiation | |
AMT-101 (IL-10 oral agonist) +anti-TNFα Details Rheumatoid arthritis | Failed Discontinued | |
AMT-101 (IL-10 oral agonist) Details Ulcerative colitis | Failed Discontinued | |
AMT-101 (IL-10 oral agonist) +anti-TNFα Details Ulcerative colitis | Failed Discontinued | |
AMT-126 (IL-22) Details GI barrier repair | Failed Discontinued |